Cargando…
Development of enteric submicron particle formulation of papain for oral delivery
BACKGROUND: Particulate systems have received increasing attention for oral delivery of biomolecules. The objective of the present study was to prepare submicron particulate formulations of papain for pH-dependent site-specific release using pH-sensitive polymers. METHODS: Enteric submicron particle...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215151/ https://www.ncbi.nlm.nih.gov/pubmed/22114474 http://dx.doi.org/10.2147/IJN.S23985 |
_version_ | 1782216342715236352 |
---|---|
author | Sharma, Manu Sharma, Vinay Panda, Amulya K Majumdar, Dipak K |
author_facet | Sharma, Manu Sharma, Vinay Panda, Amulya K Majumdar, Dipak K |
author_sort | Sharma, Manu |
collection | PubMed |
description | BACKGROUND: Particulate systems have received increasing attention for oral delivery of biomolecules. The objective of the present study was to prepare submicron particulate formulations of papain for pH-dependent site-specific release using pH-sensitive polymers. METHODS: Enteric submicron particle formulations of papain were prepared by w/o/w emulsion solvent evaporation using hydroxypropyl methylcellulose phthalate (HPMCP), Eudragit L100, and Eudragit S100, to avoid gastric inactivation of papain. RESULTS: Smaller internal and external aqueous phase volumes provided maximum encapsulation efficiency (75.58%–82.35%), the smallest particle size (665.6–692.4 nm), and 25%–30% loss of enzyme activity. Release studies in 0.1 N HCl confirmed the gastroresistance of the formulations. The anionic submicron particles aggregated in 0.1 N HCl (ie, gastric pH 1.2) due to protonation of carboxylic groups in the enteric polymer. Aggregates < 500 μm size would not impede gastric emptying. However, at pH > 5.0 (duodenal pH), the submicron particles showed deaggregation due to restoration of surface charge. HPMCP submicron particles facilitated almost complete release of papain within 30 minutes at pH 6.0, while Eudragit L100 and Eudragit S100 particles released 88.82% and 53.00% of papain at pH 6.8 and pH 7.4, respectively, according to the Korsmeyer–Peppas equation. Sodium dodecyl sulfate polyacrylamide gel electrophoresis and fluorescence spectroscopy confirmed that the structural integrity of the enzyme was maintained during encapsulation. Fourier transform infrared spectroscopy revealed entrapment of the enzyme, with powder x-ray diffraction and differential scanning calorimetry indicating an amorphous character, and scanning electron microscopy showing that the submicron particles had a spherical shape. CONCLUSION: In simulated gastrointestinal pH conditions, the HPMCP, Eudragit L100, and Eudragit S100 submicron particles showed good digestion of paneer and milk protein, and could serve as potential carriers for oral enzyme delivery. Stability studies indicated that formulations with approximately 6% overage would ensure a two-year shelf-life at room temperature. |
format | Online Article Text |
id | pubmed-3215151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-32151512011-11-23 Development of enteric submicron particle formulation of papain for oral delivery Sharma, Manu Sharma, Vinay Panda, Amulya K Majumdar, Dipak K Int J Nanomedicine Original Research BACKGROUND: Particulate systems have received increasing attention for oral delivery of biomolecules. The objective of the present study was to prepare submicron particulate formulations of papain for pH-dependent site-specific release using pH-sensitive polymers. METHODS: Enteric submicron particle formulations of papain were prepared by w/o/w emulsion solvent evaporation using hydroxypropyl methylcellulose phthalate (HPMCP), Eudragit L100, and Eudragit S100, to avoid gastric inactivation of papain. RESULTS: Smaller internal and external aqueous phase volumes provided maximum encapsulation efficiency (75.58%–82.35%), the smallest particle size (665.6–692.4 nm), and 25%–30% loss of enzyme activity. Release studies in 0.1 N HCl confirmed the gastroresistance of the formulations. The anionic submicron particles aggregated in 0.1 N HCl (ie, gastric pH 1.2) due to protonation of carboxylic groups in the enteric polymer. Aggregates < 500 μm size would not impede gastric emptying. However, at pH > 5.0 (duodenal pH), the submicron particles showed deaggregation due to restoration of surface charge. HPMCP submicron particles facilitated almost complete release of papain within 30 minutes at pH 6.0, while Eudragit L100 and Eudragit S100 particles released 88.82% and 53.00% of papain at pH 6.8 and pH 7.4, respectively, according to the Korsmeyer–Peppas equation. Sodium dodecyl sulfate polyacrylamide gel electrophoresis and fluorescence spectroscopy confirmed that the structural integrity of the enzyme was maintained during encapsulation. Fourier transform infrared spectroscopy revealed entrapment of the enzyme, with powder x-ray diffraction and differential scanning calorimetry indicating an amorphous character, and scanning electron microscopy showing that the submicron particles had a spherical shape. CONCLUSION: In simulated gastrointestinal pH conditions, the HPMCP, Eudragit L100, and Eudragit S100 submicron particles showed good digestion of paneer and milk protein, and could serve as potential carriers for oral enzyme delivery. Stability studies indicated that formulations with approximately 6% overage would ensure a two-year shelf-life at room temperature. Dove Medical Press 2011 2011-09-23 /pmc/articles/PMC3215151/ /pubmed/22114474 http://dx.doi.org/10.2147/IJN.S23985 Text en © 2011 Sharma et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Sharma, Manu Sharma, Vinay Panda, Amulya K Majumdar, Dipak K Development of enteric submicron particle formulation of papain for oral delivery |
title | Development of enteric submicron particle formulation of papain for oral delivery |
title_full | Development of enteric submicron particle formulation of papain for oral delivery |
title_fullStr | Development of enteric submicron particle formulation of papain for oral delivery |
title_full_unstemmed | Development of enteric submicron particle formulation of papain for oral delivery |
title_short | Development of enteric submicron particle formulation of papain for oral delivery |
title_sort | development of enteric submicron particle formulation of papain for oral delivery |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215151/ https://www.ncbi.nlm.nih.gov/pubmed/22114474 http://dx.doi.org/10.2147/IJN.S23985 |
work_keys_str_mv | AT sharmamanu developmentofentericsubmicronparticleformulationofpapainfororaldelivery AT sharmavinay developmentofentericsubmicronparticleformulationofpapainfororaldelivery AT pandaamulyak developmentofentericsubmicronparticleformulationofpapainfororaldelivery AT majumdardipakk developmentofentericsubmicronparticleformulationofpapainfororaldelivery |